Connect← Return to Strontium citrate, fractures and lack of research
Discussion
Strontium citrate, fractures and lack of research
Osteoporosis & Bone Health | Last Active: Jul 12 8:19pm | Replies (235)Comment receiving replies
@glojo as you probably know, approval of strontium ranelate was withdrawn in Europe for awhile due to cardiovascular effects, and is now used sparingly for patients who cannot take anything else. I assume this was the result of research.
I don't know if the controversy over distortion of DEXA's reflects concern for measuring or concern that bone density actually hasn't improved. Even that is unclear. If it is just about measuring, we should be able to take a leap of faith and use it in order to build bone, knowing that bone growth cannot be quantified.
But if the denser weight of strontium only makes bones appear to be denser, when they aren't, then we should probably avoid using it.
This seems to be a very basic question. Does the denser quality (heavier weight) of strontium actually mean better bones? Or does it just cause a false impression of growth on DEXA?
Replies to "@glojo as you probably know, approval of strontium ranelate was withdrawn in Europe for awhile due..."
Connect
Agree! Another basic question, at least it seems to me, is whether the European issue was a strontium or a strontium compound problem, ranelate versus citrate. The human-based research is largely with sodium ranelate, but it’s questionable to assign its benefits to strontium citrate, without also mentioning the risks, unless there is more study specifically with the citrate compound. Can’t have it both ways, at least in my opinion.